insights_auto
Why is MVIR up 21.00%?
Dive Deeperchevron_right
MVIR:STO
Medivir AB
SEKÂ 1.45
arrow_upward
+21.00%(+0.25) 1D
Nov 9, 5:29:37 PM GMT+1 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MVIR...
Open
SEKÂ 1.22
High
SEKÂ 1.55
Low
SEKÂ 1.22
Mkt. cap
906.31M
Avg. vol.
1.63M
Volume
10.81M
52-wk high
SEKÂ 2.88
52-wk low
SEKÂ 0.34
EPS
-SEKÂ 0.37
Shares outstanding
624.18M
No. of employees
6
Open
SEKÂ 1.22
High
SEKÂ 1.55
Low
SEKÂ 1.22
Mkt. cap
906.31M
Avg. vol.
1.63M
Volume
10.81M
52-wk high
SEKÂ 2.88
52-wk low
SEKÂ 0.34
EPS
-SEKÂ 0.37
Shares outstanding
624.18M
No. of employees
6
News stories
From web sources and news partners
24/7 Wall St.
·
36 minutes ago
Verizon’s Dividends Kept $1,000 Afloat at $1,580 While the S&P 500 Reached $3,910
Coinpaper
·
2 minutes ago
Tech Stocks Trade Cheaper Than S&P 500 for First Time Since 2017 as AI Selloff Reshapes Valuations
FXEmpire
·
2 minutes ago
NASDAQ Index, SP500, Dow Jones Forecasts – NASDAQ Soars As Traders Buy The Dip
Yahoo Finance
·
1 hour ago
S&P 500 Just Wiped Out $3 Trillion: Why This 0.35-Beta Stock is a Safe Haven
Profile
Medivir is a Swedish biotech company. Medivir focuses its research focus on oncology and particularly on innovative pharmaceuticals that meet substantial unmet medical needs. The pharmaceutical development work is conducted both in-house and through partnerships, usually with global pharmaceutical companies.
Medivir has a leading expertise in the design of protease inhibitors and in the science of nucleotides and nucleosides.
Medivir is listed on the Nasdaq Stockholm Mid Cap List.
In February 2020, Medivir announced that the company has signed a licensing agreement for Xerclear with Chinese company Shijiazhuang Yuanmai Biotechnology Co Ltd. The agreement gives SYB the right to register, manufacture and market the product in China. Wikipedia
About Medivir AB
CEOChristine Lind
Employees6
Founded1988
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websitemedivir.com